Search

Search Constraints

You searched for: Author/Creator Clavarezza, Matteo

Search Results

1. An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab. (November 2014)

2. An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab. (November 2014)

3. AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma. Issue 9 (1st September 2016)

4. Dose‐Dense FEC Followed by Dose‐Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study. (12th August 2013)

5. Dose‐Dense FEC Followed by Dose‐Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study. (26th September 2013)

6. Early onset metastatic colorectal cancer in patients receiving panitumumab‐based upfront strategy: Overall and sex‐specific outcomes in the Valentino trial. Issue 10 (23rd June 2022)

7. Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study. (August 2021)

8. Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. (August 2020)

9. Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer. (February 2021)

10. Patient‐ versus physician‐reported outcomes in a low‐dose tamoxifen trial in noninvasive breast cancer. Issue 11 (8th October 2021)